Malignant pleural mesothelioma: When is radiation therapy indicated?

Expert Review of Anticancer Therapy

Volumn 11, Issue 4, 2011, Pages 551-560

  Van Thiel, Eric Re ^a   Surmont, Veerle F ^a   Van Meerbeeck, Jan P ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

cancer; guidelines; mesothelioma; pleura; radiotherapy treatment

Indexed keywords

CISPLATIN; PEMETREXED;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER STAGING; CYTOREDUCTIVE SURGERY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRAOPERATIVE RADIOTHERAPY; LUNG RESECTION; MALIGNANT MESOTHELIOMA; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PLEURA MESOTHELIOMA; PLEURECTOMY; REVIEW; THORAX RADIOGRAPHY; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS;

EID: 79955122845     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.169     Document Type: Review

References (50)

1. Travis WB, Müller-Hermelink HK, Harris CC. World Health Organization classification of tumours. Tumours of the lung, pleura, thymus and heart. IARC, Lyon, France (2004).
2. Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet 366, 397-408 (2005). (Pubitemid 41073959)
3. Testa JR, Pass HI, Carbone M. Benign and malignant mesothelioma. Principles and Practice of Oncology (6th Editon).Lippincott Williams & Wilkins, PA, USA, 1937 (2001).
4. Rusch VW, Rosenzweig K, Venkatraman E et al. A Phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 122, 788-795 (2001).
5. Boutin C, Rey F, Gouvernet J et al. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Cancer 72, 394-404 (1993). (Pubitemid 23193444)
6. Rusch VM; The International Mesothelioma Interest Group (IMIG).A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 108, 1122-1128 (1995).
7. Francart J, Vaes E, Henrard S et al. A prognostic index for progression free survival in malignant mesothelioma with application to the design of Phase II trial: an analysis of 10 combined EORTC trials. Eur. J. Cancer 45, 2304-2311 (2009).
8. Eibel R, Tuengerthal S, Schoenberg SO. The role of new imaging techniques in diagnosis and staging of malignant pleural mesothelioma. Curr. Opin. Oncol. 15, 131-138 (2003). (Pubitemid 36324219)
9. Wang ZJ, Reddy GP, Gotway MB et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 24, 105-119 (2004). (Pubitemid 38134597)
10. Plathow C, Staab A, Schmaehl A et al. Computed tomography, positron emission tomography, positron emission tomography/ computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results. Invest. Radiol. 43(10), 737-744 (2008).
11. Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol. 21, 2636-2644 (2003). (Pubitemid 46606305)
12. Van Meerbeeck JP, Manegold C, Gaafar R et al. A randomized Phase III study of cisplatine with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the EORTC lung cancer group and NCIC. J. Clin. Oncol. 23, 6881-6889 (2005).
13. Gordon W, Antman KH, Greenberger JS et al. Radiation therapy in the management of patients with mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 8, 19-25 (1982). (Pubitemid 12136700)
14. Bissett D, Macbeth FR, Cram I. The role of palliative radiotherapy in malignant mesothelioma. Clin. Oncol. (R. Coll. Radiol.) 3, 315-317 (1991).
15. Ball DL, Cruickshank DG. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. Am. J. Clin. Oncol. 13, 4-9 (1990). (Pubitemid 20114548)
16. De Graaf-Strukowska L, Van der Zee J, Van Putten W et al. Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura - a single-institution experience with 189 patients. Int. J. Radiat. Oncol. Biol. Phys. 43(3), 511-516 (1999). (Pubitemid 29107168)
17. Van der Zee J, van de Pol M, Praag JO. Letter to the editor. Radiother. Oncol. 70, 99 (2004). (Pubitemid 38177169)
18. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 108, 754-758 (1995).
19. Bydder S, Phillips M, Joseph DJ et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br. J. Cancer 91, 9-10 (2004). (Pubitemid 39013037)
20. O'Rourke N, Garcia JC, Paul J et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother. Oncol. 84, 18-22 (2007). (Pubitemid 47030694)
21. Muirhead R, O'Rourke N. Drain site radiotherapy in malignant pleural mesothelioma: a wasted resource. Eur. Respir. J. 30, 1021-1022 (2007).
22. Ung YC, Yu E, Falkson C et al. The role of radiation therapy in malignant pleural mesothelioma: a systematic review. Radiother. Oncol. 80, 3-8 (2006).
23. De Ruysscher D, Slotman B. Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey. Radiother. Oncol. 68, 299-302 (2003). (Pubitemid 38373432)
24. Senan S. Indications and limitations of radiotherapy in malignant pleural mesothelioma, Curr. Opin. Oncol. 15, 144-147 (2003). (Pubitemid 36324221)
25. Hilaris BS, Nori D, Kwong E et al. Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 10, 325-331 (1984). (Pubitemid 14110165)
26. Law MR, Gregor A, Hodson ME et al. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 39, 255-259 (1984). (Pubitemid 14169569)
27. Alberts AS, Falkson G, Goedhals L et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J. Clin. Oncol. 6, 527-535 (1988). (Pubitemid 18090702)
28. Sugarbaker DJ, Garcia JP, Richards WG et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann. Surg. 224, 288-294 (1996).
29. Gupta V, Mychalczak B, Krug L et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 63, 1045-1052 (2005). (Pubitemid 41505282)
30. Kutcher GJ, Kestler C, Greenblat D et al. Technique for external beam treatment for mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 13, 1747-1752 (1987). (Pubitemid 17160140)
31. Achatzy R, Beba W, Ritschler R et al. The diagnosis, therapy and prognosis of diffuse malignant mesothelioma. Eur. J. Cardiothorac. Surg. 3, 445-448 (1989).
32. Soysal O, Karaoglanoglu N, Demircan S et al. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur. J. Cardiothorac. Surg. 11, 210-213 (1997). (Pubitemid 27096656)
33. Ahamed A, Stevens CW, Smythe WR et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 55, 768-775 (2003). (Pubitemid 36170016)
34. Yajnik S, Rosenzweig KE, Mychalczak B et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 56, 1319-1326 (2003). (Pubitemid 36842883)
35. Forster KM, Smythe WR, Starkschall G et al. Intensity modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int. J. Radiat. Oncol. Biol. Phys. 55, 606-616 (2003). (Pubitemid 36170001)
36. Van Meerbeeck JP, Surmont VF, Scherpereel A et al. Malignant pleural mesothelioma: the standard of care and challenges for future management. Crit. Rev. Oncol. Hematol. DOI: 10.1016/j. critrevonc.2010.04.004 (2010) (Epub ahead of print).
37. Rice DC, Stevens CW, Correa AM et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann. Thorac. Surg. 84, 1685-1693 (2007). (Pubitemid 47588107)
38. Miles EF, Larrier NA, Kelsey CR et al. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience. Int. J. Radiat. Oncol. Biol. Phys. 71, 1143-1150 (2008).
39. Rice DC, Smythe WR, Stevens C et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 69, 350-347 (2007).
40. Rosenzweig K, Krug L, Laser B et al. Feasibility of pleural intensity-modulated radiation therapy (IMRT) for malignant mesothelioma. J. Thor. Oncol. 4(9), S774 (2009).
41. Krayenbuehl J, Hartmann M, Lomax AJ et al. Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy. Int. J. Radiat. Oncol. Biol. Phys. 77, 942-949 (2010).
42. Sugarbaker DJ, Flores RM, Jaklitsch MT et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J. Thorac. Cardiovasc. Surg. 117, 54-63 (1999).
43. Flores RM, Pass HI, Seshan VE et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J. Thorac. Cardiovasc. Surg. 135, 620-626 (2008).
44. Weder W, Stahel RA, Bernhard J et al.; Swiss Group for Clinical Cancer Research (SAKK).Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann. Oncol. 18, 1196-1202 (2007). (Pubitemid 47244366)
45. Krug LM, Pass HI, Rusch VW et al. Multicenter Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J. Clin. Oncol. 27, 3007-3013 (2009).
46. de Perrot M, Feld R, Choy BC et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J. Clin. Oncol. 27, 1413-1418 (2009).
47. Van Schil PE, Baas P, Gaafar R et al. Phase II trial of trimodality therapy for malignant pleural mesothelioma (EORTC 08031).Eur. Respir. J. 36(6), 1362-1369 (2010).
48. Hillerdal G, Sorensen JB, Sundström S et al. Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a Phase II study. J. Thorac. Oncol. 3, 1325-1331 (2008).
49. Treasure T, Waller D, Tan C et al. The Mesothelioma and Radical Surgery randomized controlled trial: the MARS feasibility study. J. Thorac. Oncol. 4, 1254-1258 (2009).
50. Scherpereel A, Astoul P, Baas P et al. Guidelines of the ERS/ESTS for management of malignant pleural mesothelioma. Eur. Resp. J. 35, 479-495 (2010).